InVivoMAb anti-human Ganglioside GD2

Clone Catalog # Category
14G2a BE0318 InVivoMab Antibodies
$95 - $3250
SDS Sheet

About InVivoMAb anti-human Ganglioside GD2

The 14G2a monoclonal antibody reacts with human ganglioside GD2 a sialic-acid bearing glycolipid that is involved in mediating cell attachment to the extracellular matrix. Ganglioside GD2 is expressed on tumors of neuroectodermal origin including human neuroblastoma and melanoma. The tumor specific expression of GD2 makes it a suitable target for immunotherapy with monoclonal antibodies or with artificial T cell receptors. Clone 14G2a is an isotype switch variant selected from the parental IgG3-producing hybridoma 14.18 and has identical reactivity as the parental antibody.

InVivoMAb anti-human Ganglioside GD2 Specifications


Mouse IgG2a, κ

Recommended Isotype Control(s) InVivoMAb mouse IgG2a isotype control, unknown specificity(BE0085)
Recommended InVivoPure Dilution Buffer InVivoPure pH 7.0 Dilution Buffer(IP0070)

Neuroblastoma cell line LAN-1

Reported Applications
  • in vitro induction of apoptosis in GD2+ cells
  • in vivo inhibition of GD2+ tumor cell growth
  • PBS, pH 7.0
  • Contains no stabilizers or preservatives
  • <2EU/mg (<0.002EU/μg)
  • Determined by LAL gel clotting assay
  • >95%
  • Determined by SDS-PAGE

0.2 μM filtered


Purified from tissue culture supernatant in an animal free facility


Protein A


Undiluted at 4°C in the dark

References provided by Bioz:

Disclaimer: These articles are provided by Bioz, an automated third-party article search engine. Given Bioz’s automation, these articles may not reflect the reported applications listed for this product. For an extensive up-to-date article list directly tailored to the reported applications listed for this product please see the Bio X Cell Application References by clicking the green button above.

Powered by Bioz

We're Heading to AACR

Come visit us at Booth 1842! See you in Atlanta!